Literature DB >> 2044556

Chronic non-ischaemic congestive heart disease and endomyocardial biopsies. Worth the extra?

A E Becker1, C D Heijmans, C E Essed.   

Abstract

The diagnostic yield of endomyocardial biopsies in patients with chronic congestive heart failure of non-ischaemic aetiology remains questionable and, therefore, the use of endomyocardial biopsies under such circumstances is at stake. The present report documents the correlation between the histologic interpretation of endomyocardial biopsies and the corresponding cardiac explants in 13 patients who underwent cardiac transplantation. The biopsy diagnoses in these patients varied from 'compatible with dilated cardiomyopathy' (n = 6) to 'non-conclusive' (n = 4), 'ischaemia' (n = 2) and 'borderline myocarditis' (n = 1). Correlation with the corresponding cardiac explants revealed hypertrophy of myocytes as the leading histologic feature in the majority of cases. Because of the non-specific histopathology of dilated cardiomyopathy, the discrepancy between biopsy diagnoses and the leading explant diagnosis is mostly a matter of semantics. Ischaemia was present at high incidence, but is considered a result of imparied myocardial perfusion rather than the prime mechanism of heart failure. In four cardiac explants myocarditis was encountered, while the corresponding biopsies showed no cellular inflammation. In two, the cellular infiltrates suggested an early state of repair. One heart contained an active and extensive lymphocytic myocarditis. The fourth case showed an eosinophilic myocarditis, most likely acquired after the biopsy was taken. These discrepancies almost certainly relate to the sampling error and the time interval between biopsy and onset of symptoms. The immediate diagnostic yield of the biopsy, in this particular subset of patients, was minimal, particularly with respect to the diagnosis 'myocarditis'. Nevertheless, biopsy diagnoses such as 'compatible with' and 'non-conclusive' do contribute to the final categorization and management of these patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 2044556     DOI: 10.1093/oxfordjournals.eurheartj.a059872

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

1.  Diagnosis of heart failure.

Authors:  J Cleland
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

2.  Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis.

Authors:  Francesco Sardanelli; Simone Schiaffino; Moreno Zanardo; Francesco Secchi; Paola Maria Cannaò; Federico Ambrogi; Giovanni Di Leo
Journal:  Eur Radiol       Date:  2019-05-02       Impact factor: 5.315

3.  Myocardial T1 mapping: techniques and potential applications.

Authors:  Jeremy R Burt; Stefan L Zimmerman; Ihab R Kamel; Marc Halushka; David A Bluemke
Journal:  Radiographics       Date:  2014 Mar-Apr       Impact factor: 5.333

Review 4.  Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.

Authors:  Jonathan P Law; Luke Pickup; Davor Pavlovic; Jonathan N Townend; Charles J Ferro
Journal:  J Hum Hypertens       Date:  2022-09-22       Impact factor: 2.877

Review 5.  Myocardial Tissue Characterization: Histological and Pathophysiological Correlation.

Authors:  T A Treibel; S K White; J C Moon
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014

Review 6.  Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities.

Authors:  M P M Graham-Brown; A S Patel; D J Stensel; D S March; A-M Marsh; J McAdam; G P McCann; J O Burton
Journal:  Biomed Res Int       Date:  2017-03-02       Impact factor: 3.411

7.  Kidney transplantation is associated with reduced myocardial fibrosis. A cardiovascular magnetic resonance study with native T1 mapping.

Authors:  Mariana Moraes Contti; Maurício Fregonesi Barbosa; Alejandra Del Carmen Villanueva Mauricio; Hong Si Nga; Mariana Farina Valiatti; Henrique Mochida Takase; Ariane Moyses Bravin; Luis Gustavo Modelli de Andrade
Journal:  J Cardiovasc Magn Reson       Date:  2019-03-27       Impact factor: 5.364

8.  Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.

Authors:  Hua-Yan Xu; Zhi-Gang Yang; Yi Zhang; Wan-Lin Peng; Chun-Chao Xia; Zhen-Lin Li; Yong He; Rong Xu; Li Rao; Ying Peng; Yu-Ming Li; Hong-Ling Gao; Ying-Kun Guo
Journal:  BMC Cardiovasc Disord       Date:  2020-01-10       Impact factor: 2.298

9.  Quantification of extracellular volume fraction by cardiac computed tomography for noninvasive assessment of myocardial fibrosis in hemodialysis patients.

Authors:  Akimasa Yamada; Kakuya Kitagawa; Satoshi Nakamura; Masafumi Takafuji; Yoshitaka Goto; Ryuji Okamoto; Kaoru Dohi; Hajime Sakuma
Journal:  Sci Rep       Date:  2020-09-21       Impact factor: 4.379

Review 10.  Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy.

Authors:  Jonathan P Law; Anna M Price; Luke Pickup; Ashwin Radhakrishnan; Chris Weston; Alan M Jones; Helen M McGettrick; Winnie Chua; Richard P Steeds; Larissa Fabritz; Paulus Kirchhof; Davor Pavlovic; Jonathan N Townend; Charles J Ferro
Journal:  J Am Heart Assoc       Date:  2020-03-26       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.